Extra-hepatic cancer represses hepatic drug metabolism via interleukin (IL)-6 signalling.
about
Color Doppler ultrasound and gamma imaging of intratumorally injected 500 nm iron-silica nanoshells.Integrin Receptors Play a Key Role in the Regulation of Hepatic CYP3A.Cancer, inflammation, and therapy: effects on cytochrome p450-mediated drug metabolism and implications for novel immunotherapeutic agents.Pharmacokinetics, pharmacodynamics and pharmacogenetics associated with nonsteroidal anti-inflammatory drugs and opioids in pediatric cancer patients.Cancer-Related Systemic Inflammation: The Challenges and Therapeutic Opportunities for Personalized Medicine.
P2860
Extra-hepatic cancer represses hepatic drug metabolism via interleukin (IL)-6 signalling.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Extra-hepatic cancer represses hepatic drug metabolism via interleukin (IL)-6 signalling.
@en
Extra-hepatic cancer represses hepatic drug metabolism via interleukin
@nl
type
label
Extra-hepatic cancer represses hepatic drug metabolism via interleukin (IL)-6 signalling.
@en
Extra-hepatic cancer represses hepatic drug metabolism via interleukin
@nl
prefLabel
Extra-hepatic cancer represses hepatic drug metabolism via interleukin (IL)-6 signalling.
@en
Extra-hepatic cancer represses hepatic drug metabolism via interleukin
@nl
P2093
P2860
P1476
Extra-hepatic cancer represses hepatic drug metabolism via interleukin (IL)-6 signalling.
@en
P2093
Andre Mahns
Christopher Liddle
Graham R Robertson
Marina Kacevska
Rohini Sharma
Stephen J Clarke
P2860
P304
P356
10.1007/S11095-013-1042-3
P577
2013-04-20T00:00:00Z